COUNTDOWN TO OMERACT 2027!

Day

Hour

Minute

Second

OMERACT 2027

May 19–23, 2027 | Kingbridge Centre, Toronto, Canada

Developing Core Outcome Sets Through Collaboration

OMERACT 2027 Draft Program Now Available

We are pleased to share the draft program for OMERACT 2027, taking place May 19–23, 2027 at the Kingbridge Centre in Toronto, Canada.

The draft program provides an overview of the planned scientific sessions, including plenaries, Special Interest Group sessions, the Prevention Symposium, methods programming, Patient Research Partner engagement, Fellows activities, networking opportunities, and social events.

Please note that the program remains draft and subject to change as session planning continues.

OMERACT 2027 Scientific Program: Sessions Selected

We are pleased to announce that the Special Interest Group (SIG) sessions, Workshops, and Symposium for OMERACT 2027 have been formally selected following review of Working Group applications.

The 2027 program reflects the full breadth of OMERACT activity, spanning core domain set endorsement, instrument selection, composite outcome development, imaging, and methodological innovation, with strong integration of patient engagement and equity considerations across sessions.

Workshop/Plenaries

The 2027 workshops will focus on advancing methodological rigor and practical guidance across OMERACT processes:

Patient Engagement
Equity, Diversity & Inclusivity (EDI)
OMERACT Methodology

These sessions are designed to produce actionable outputs, including guidance, tools, and frameworks to support Working Groups across the OMERACT pathway.

Symposium: Prevention and Risk-Stage Rheumatic Disease: Rethinking Outcomes, Core Sets, and OMERACT’s Role

This cross-cutting symposium will address a major emerging challenge in rheumatology research: how to define and measure outcomes in prevention and early disease states.

Key themes include:

Defining “at-risk” populations
Identifying appropriate endpoints beyond disease onset
Integrating patient-reported outcomes in prevention contexts
Addressing regulatory and industry considerations

As trials move earlier in the disease trajectory, this session will explore whether new or adapted core outcome frameworks are required, and what role OMERACT should play in shaping this space

Special Interest Group (SIG) Sessions

Composite Outcome Development

Flares in Osteoarthritis (OA)
Remission in Rheumatoid Arthritis (RA): Patient Perspective

Core Domain Set Development

Sjögren’s Disease

Imaging

MRI Taskforce
Ultrasound

Methods

Patient Preferences to Value Health Outcomes for RCT's

Instrument Selection

Behçet’s Syndrome & Large Vessel Vasculitis
Foot & Ankle Disorders
Juvenile Idiopathic Arthritis (JIA) & JIA Flare
Myositis
Pain
Safety
Scleroderma Vascular Disease
Shared Decision Making
Shoulder Disorders
Systemic Lupus Erythematosus (SLE)

KEY DATES

Stay on track with important milestones leading up to OMERACT 2027. Deadlines are aligned to ensure Working Groups, PRPs, and delegates have time to prepare, collaborate, and participate fully.

Early Bird Registration Opens Fall 2026
May 19–23 2027 – Conference

OMERACT Conference Frequently Asked Questions

What is an OMERACT Conference?

An OMERACT Conference is a biennial gathering of healthcare professionals, researchers, methodologists, and patient research partners who are committed to advancing the field of rheumatology outcome measures. The conference provides a dynamic forum for presenting and discussing cutting-edge research, fostering collaboration across disciplines. A hallmark of OMERACT Conferences is the emphasis on reaching consensus through evidence-based discussions, allowing for the development and refinement of outcome measures that are both scientifically robust and clinically meaningful.

The structure of the conference, with its plenary sessions offering high-level overviews of key issues and various working group sessions providing opportunities for more targeted discussions, ensures that attendees gain practical insights and knowledge. This diverse agenda, which balances scientific rigor with practical application, makes OMERACT Conferences an invaluable resource for anyone involved in the research and practice of rheumatology outcome measures.

To complete the What to Expect at an OMERACT Conference e-learning module, click here

How do I register for the Conference?

Registration will be completed online through the OMERACT 2027 registration portal, which will open on November 1, 2026.

Participants will be asked to:

Select a registration category
Confirm eligibility where applicable, for example Patient Research Partner, Fellow, Emerging Leader, or Low/Middle Income Country
Complete payment to secure their place

Because registration numbers are capped in each category, early registration is strongly encouraged.

Registration Fees and Categories for OMERACT 2027

All-Inclusive Registration Options

Early Registration - $2,975 USD
Available November 1, 2026 to February 28, 2027

Standard All-Inclusive Registration - $3,475 USD
Available March 1, 2027 to May 1, 2027

Shared Room Option - $2,725 USD
Accommodation is shared with another participant

What Is Included with All-Inclusive Registration

Four nights’ accommodation at the conference hotel
Ground transportation between Toronto Pearson International Airport and The Kingbridge Centre for arrivals on May 19 and departures on May 23
All meals, including breakfast, lunch, all-day breaks, and dinner
Full access to plenary sessions
Full access to working group meetings
Access to all social and networking receptions

Special Registration Categories

The following categories include the All-Inclusive Registration Package described above.

Fellows and Emerging Leaders: $2,975 USD
Patient Research Partners (PRPs): $2,975 USD
Low- and Middle-Income Countries (LMIC): $2,475 USD

Off-Site Registration - $2,300 USD

For participants arranging their own accommodation

Includes

Access to all plenary sessions
Access to all working group meetings
Lunches during the conference
Farewell dinner

Accommodation, airport transfers, breakfasts, and evening dinners are not included.

Day Registration - $1,000 USD per day

Participants may register for a single conference day

Includes

Access to plenary sessions for the selected day
Access to working group meetings for the selected day
Lunch and scheduled receptions for that day

Guest Registration - $1,000 USD

For accompanying guests

Guest registration includes ground transportation, meals, and social events only and does not include access to plenary or working group sessions.

Meet the Planning Team

Philip Conaghan

Maya Desai, PRP

Shawna Grosskleg

Catherine Hofstetter, PRP

Lee Simon

Zahi Touma

Peter Tugwell

Mark Campbell, Emerging Leader

Caroline Flurey, Emerging Leader

New to OMERACT?

OMERACT Working Groups follow a structured, consensus-driven approach to developing Core Outcome Sets. Explore how this process unfolds and discover more about how OMERACT advances outcome measurement in rheumatology.

Learn More

COUNTDOWN TO OMERACT 2027!

OMERACT 2027

May 19–23, 2027 | Kingbridge Centre, Toronto, Canada

Developing Core Outcome Sets Through Collaboration

OMERACT 2027 Draft Program Now Available

OMERACT 2027 Scientific Program: Sessions Selected

We are pleased to announce that the Special Interest Group (SIG) sessions, Workshops, and Symposium for OMERACT 2027 have been formally selected following review of Working Group applications.

The 2027 program reflects the full breadth of OMERACT activity, spanning core domain set endorsement, instrument selection, composite outcome development, imaging, and methodological innovation, with strong integration of patient engagement and equity considerations across sessions.

Workshop/Plenaries

The 2027 workshops will focus on advancing methodological rigor and practical guidance across OMERACT processes:

Patient Engagement

Equity, Diversity & Inclusivity (EDI)

OMERACT Methodology

These sessions are designed to produce actionable outputs, including guidance, tools, and frameworks to support Working Groups across the OMERACT pathway.

Symposium: Prevention and Risk-Stage Rheumatic Disease: Rethinking Outcomes, Core Sets, and OMERACT’s Role

This cross-cutting symposium will address a major emerging challenge in rheumatology research: how to define and measure outcomes in prevention and early disease states.

Key themes include:

Defining “at-risk” populations

Identifying appropriate endpoints beyond disease onset

Integrating patient-reported outcomes in prevention contexts

Addressing regulatory and industry considerations

As trials move earlier in the disease trajectory, this session will explore whether new or adapted core outcome frameworks are required, and what role OMERACT should play in shaping this space

Special Interest Group (SIG) Sessions

Composite Outcome Development

Flares in Osteoarthritis (OA)

Remission in Rheumatoid Arthritis (RA): Patient Perspective

Core Domain Set Development

Sjögren’s Disease

Imaging

MRI Taskforce

Ultrasound

Methods

Patient Preferences to Value Health Outcomes for RCT's

Instrument Selection

Behçet’s Syndrome & Large Vessel Vasculitis

Foot & Ankle Disorders

Juvenile Idiopathic Arthritis (JIA) & JIA Flare

Myositis

Pain

Safety

Scleroderma Vascular Disease

Shared Decision Making

Shoulder Disorders

Systemic Lupus Erythematosus (SLE)

KEY DATES

OMERACT Conference Frequently Asked Questions

Meet the Planning Team

New to OMERACT?